<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30446446      </PMID><DateCompleted><Year>2020	</Year><Month>07	</Month><Day>23	</Day></DateCompleted><DateRevised><Year>2020	</Year><Month>07	</Month><Day>23	</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2496	  </ISSN><JournalIssue CitedMedium="Internet"><Volume>37	    </Volume><Issue>11	    </Issue><PubDate><Year>2019	      </Year><Month>11	      </Month></PubDate></JournalIssue><Title>Urologic oncology	  </Title><ISOAbbreviation>Urol Oncol	  </ISOAbbreviation></Journal><ArticleTitle>Molecular footprints of muscle-invasive bladder cancer in smoking and	nonsmoking patients.	</ArticleTitle><Pagination><MedlinePgn>818-825	  </MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1078-1439(18)30381-8	</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.urolonc.2018.09.017	</ELocationID><Abstract><AbstractText Label="BACKGROUND">Bladder cancer is the fifth most common cancer in	  the United States and smoking is the largest known risk factor. Tobacco-derived	  carcinogens may induce the accumulation of somatic mutations in urothelial cells,	  and likely promote tumorigenesis. However, it is still unknown whether	  smoking-induced bladder carcinogenesis results in tumors with distinctive molecular	  features that can be therapeutically exploited.	  </AbstractText><AbstractText Label="METHODS">We investigated the genomic alterations of human	  bladder cancer and examined their association with patient smoking history. We	  performed bioinformatic analyses and looked at differences in gene expression,	  somatic mutations, and DNA mutational signatures comparing nonsmokers, reformed	  smokers, and current smokers.	  </AbstractText><AbstractText Label="RESULTS">We detected a limited set of gene expression and gene	  mutation differences between smokers and nonsmokers. We also identified a specific	  mutational signature that is enriched in tumors from smokers. This mutational	  signature was described before and has been linked to specific DNA repair defects	  in human bladder tumors, as well as to the direct effect of nitrosamine carcinogens	  in the BBN murine model of bladder cancer.	  </AbstractText><AbstractText Label="CONCLUSION">We showed associations between smoking status and	  selected mutational signatures, which could provide insights in the biology of	  bladder carcinogenesis and tumor progression.	  </AbstractText><CopyrightInformation>Published by Elsevier Inc.	  </CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fantini	    </LastName><ForeName>Damiano	    </ForeName><Initials>D	    </Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of	      Medicine, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center,	      Northwestern University, Chicago, IL.	      </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seiler	    </LastName><ForeName>Roland	    </ForeName><Initials>R	    </Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital Bern, Bern,	      Switzerland.	      </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeks	    </LastName><ForeName>Joshua J	    </ForeName><Initials>JJ	    </Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of	      Medicine, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center,	      Northwestern University, Chicago, IL; Department of Biochemistry and Molecular	      Genetics, Northwestern University, Chicago, IL. Electronic address:	      joshua.meeks@northwestern.edu.	      </Affiliation></AffiliationInfo></Author></AuthorList><Language>eng	</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX003692	    </GrantID><Acronym>BX	    </Acronym><Agency>BLRD VA	    </Agency><Country>United States	    </Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article	  </PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018	  </Year><Month>11	  </Month><Day>13	  </Day></ArticleDate></Article><MedlineJournalInfo><Country>United States	</Country><MedlineTA>Urol Oncol	</MedlineTA><NlmUniqueID>9805460	</NlmUniqueID><ISSNLinking>1078-1439	</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0	  </RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor	  </NameOfSubstance></Chemical><Chemical><RegistryNumber>0	  </RegistryNumber><NameOfSubstance UI="D002273">Carcinogens	  </NameOfSubstance></Chemical><Chemical><RegistryNumber>0	  </RegistryNumber><NameOfSubstance UI="C103539">GPR15 protein, human	  </NameOfSubstance></Chemical><Chemical><RegistryNumber>0	  </RegistryNumber><NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled	  </NameOfSubstance></Chemical><Chemical><RegistryNumber>0	  </RegistryNumber><NameOfSubstance UI="D018000">Receptors, Peptide	  </NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.4.5	  </RegistryNumber><NameOfSubstance UI="D000071478">APOBEC Deaminases	  </NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM      </CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000071478" MajorTopicYN="N">APOBEC Deaminases	  </DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis	  </QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor	  </DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis	  </QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	  </QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis	  </DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced	  </QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002273" MajorTopicYN="N">Carcinogens	  </DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059645" MajorTopicYN="N">Mutation Rate	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078405" MajorTopicYN="N">Non-Smokers	  </DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled	  </DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis	  </QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018000" MajorTopicYN="N">Receptors, Peptide	  </DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis	  </QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074285" MajorTopicYN="N">Smokers	  </DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking	  </DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014026" MajorTopicYN="N">Tobacco	  </DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation	  </DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001743" MajorTopicYN="N">Urinary Bladder	  </DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects	  </QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms	  </DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology	  </QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality	  </QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019459" MajorTopicYN="N">Urothelium	  </DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects	  </QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology	  </QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">APOBEC mutagenesis	</Keyword><Keyword MajorTopicYN="Y">BBN mouse model	</Keyword><Keyword MajorTopicYN="Y">Bladder cancer	</Keyword><Keyword MajorTopicYN="Y">Cancer genome	</Keyword><Keyword MajorTopicYN="Y">Mutational signatures	</Keyword><Keyword MajorTopicYN="Y">Smoking-related carcinogenesis	</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018	  </Year><Month>06	  </Month><Day>06	  </Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018	  </Year><Month>08	  </Month><Day>24	  </Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018	  </Year><Month>09	  </Month><Day>03	  </Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018	  </Year><Month>11	  </Month><Day>18	  </Day><Hour>6	  </Hour><Minute>0	  </Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020	  </Year><Month>7	  </Month><Day>24	  </Day><Hour>6	  </Hour><Minute>0	  </Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018	  </Year><Month>11	  </Month><Day>18	  </Day><Hour>6	  </Hour><Minute>0	  </Minute></PubMedPubDate></History><PublicationStatus>ppublish      </PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30446446	</ArticleId><ArticleId IdType="pii">S1078-1439(18)30381-8	</ArticleId><ArticleId IdType="doi">10.1016/j.urolonc.2018.09.017	</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30421072      </PMID><DateCompleted><Year>2020	</Year><Month>02	</Month><Day>18	</Day></DateCompleted><DateRevised><Year>2020	</Year><Month>02	</Month><Day>25	</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8726	  </ISSN><JournalIssue CitedMedium="Internet"><Volume>37	    </Volume><Issue>9	    </Issue><PubDate><Year>2019	      </Year><Month>Sep	      </Month></PubDate></JournalIssue><Title>World journal of urology	  </Title><ISOAbbreviation>World J Urol	  </ISOAbbreviation></Journal><ArticleTitle>Genomic classification and risk stratification of bladder cancer.	</ArticleTitle><Pagination><MedlinePgn>1751-1757	  </MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-018-2558-2	</ELocationID><Abstract><AbstractText>Bladder cancer is the fourth most common cancer in men and fifth most	  common overall. The use of next-generation sequencing (NGS) approaches is crucial	  to precisely characterize the molecular defects of tumors, and this information	  could be combined with other clinical data, such as tumor histology and TNM	  staging, with the goal of precise tumor classification. In many settings, targeted	  NGS is evaluated in patients with first- and second-line metastatic cancer. Yet, in	  the decade to come we anticipate increased application of precision oncology at all	  stages of bladder cancer with the aim of customizing cancer treatment. Here, we	  review the genomic and transcriptomic features associated with risk stratification	  in bladder cancer and summarize the current efforts for precision oncology in	  localized urothelial carcinomas.	  </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fantini	    </LastName><ForeName>Damiano	    </ForeName><Initials>D	    </Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Chicago, IL, USA.	      </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School	      of Medicine, Chicago, IL, USA.	      </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Cancer Center, Chicago, IL, USA.	      </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeks	    </LastName><ForeName>Joshua J	    </ForeName><Initials>JJ	    </Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Chicago, IL,	      USA. joshua.meeks@northwestern.edu.	      </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School	      of Medicine, Chicago, IL, USA. joshua.meeks@northwestern.edu.	      </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Cancer Center, Chicago, IL,	      USA. joshua.meeks@northwestern.edu.	      </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jesse Brown VA Medical Center, Chicago, IL, USA. joshua.meeks@northwestern.edu.	      </Affiliation></AffiliationInfo></Author></AuthorList><Language>eng	</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX003692	    </GrantID><Acronym>BX	    </Acronym><Agency>BLRD VA	    </Agency><Country>United States	    </Country></Grant><Grant><GrantID>BX003692	    </GrantID><Agency>Office of Research and Development	    </Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article	  </PublicationType><PublicationType UI="D016454">Review	  </PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018	  </Year><Month>11	  </Month><Day>12	  </Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany	</Country><MedlineTA>World J Urol	</MedlineTA><NlmUniqueID>8307716	</NlmUniqueID><ISSNLinking>0724-4983	</ISSNLinking></MedlineJournalInfo><CitationSubset>IM      </CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness	  </DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment	  </DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods	  </QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms	  </DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification	  </QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics	  </QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology	  </QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker	</Keyword><Keyword MajorTopicYN="N">Bladder cancer	</Keyword><Keyword MajorTopicYN="N">Classifier	</Keyword><Keyword MajorTopicYN="N">Genetic mutation	</Keyword><Keyword MajorTopicYN="N">Risk-classification	</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018	  </Year><Month>09	  </Month><Day>10	  </Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018	  </Year><Month>11	  </Month><Day>03	  </Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018	  </Year><Month>11	  </Month><Day>14	  </Day><Hour>6	  </Hour><Minute>0	  </Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020	  </Year><Month>2	  </Month><Day>19	  </Day><Hour>6	  </Hour><Minute>0	  </Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018	  </Year><Month>11	  </Month><Day>14	  </Day><Hour>6	  </Hour><Minute>0	  </Minute></PubMedPubDate></History><PublicationStatus>ppublish      </PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30421072	</ArticleId><ArticleId IdType="doi">10.1007/s00345-018-2558-2	</ArticleId><ArticleId IdType="pii">10.1007/s00345-018-2558-2	</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Urology. 2005 Dec;66(6 Suppl 1):4-34	  </Citation><ArticleIdList><ArticleId IdType="pubmed">16399414	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7	  </Citation><ArticleIdList><ArticleId IdType="pubmed">16442208	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2010 Apr 1;16(7):2131-7	  </Citation><ArticleIdList><ArticleId IdType="pubmed">20233890	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2012 Jun 15;18(12):3377-86	  </Citation><ArticleIdList><ArticleId IdType="pubmed">22553347	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Aug 22;500(7463):415-21	  </Citation><ArticleIdList><ArticleId IdType="pubmed">23945592	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Mar 20;507(7492):315-22	  </Citation><ArticleIdList><ArticleId IdType="pubmed">24476821	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3110-5	  </Citation><ArticleIdList><ArticleId IdType="pubmed">24520177	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2014 Oct;4(10):1140-53	  </Citation><ArticleIdList><ArticleId IdType="pubmed">25096233	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Virchows Arch. 2015 Mar;466(3):297-311	  </Citation><ArticleIdList><ArticleId IdType="pubmed">25502898	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2015 Nov;68(5):824-32; discussion 835-6	  </Citation><ArticleIdList><ArticleId IdType="pubmed">25770486	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2015 Dec;68(6):959-67	  </Citation><ArticleIdList><ArticleId IdType="pubmed">26238431	    </ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Oncol. 2016 Aug 1;2(8):1094-6	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27310333	    </ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2016 Oct;196(4):1021-9	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27317986	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2016 Jul 11;30(1):27-42	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27321955	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2017 Mar;71(3):447-461	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27324428	    </ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Compr Canc Netw. 2016 Oct;14(10):1213-1224	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27697976	    </ArticleId></ArticleIdList></Reference><Reference><Citation>JCI Insight. 2016 Mar 17;1(3):e85902	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27699256	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2016 Nov 15;7(46):75176-75184	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27750214	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2017 Jun 15;23(12):3003-3011	  </Citation><ArticleIdList><ArticleId IdType="pubmed">27932416	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Urol. 2017 Feb 07;14(4):215-229	  </Citation><ArticleIdList><ArticleId IdType="pubmed">28169993	    </ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2017 May;242(1):113-125	  </Citation><ArticleIdList><ArticleId IdType="pubmed">28195647	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2017 Jun 1;123(11):1912-1924	  </Citation><ArticleIdList><ArticleId IdType="pubmed">28323334	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2017 Oct;72(4):544-554	  </Citation><ArticleIdList><ArticleId IdType="pubmed">28390739	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Oct 19;171(3):540-556.e25	  </Citation><ArticleIdList><ArticleId IdType="pubmed">28988769	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Nov 2;171(4):934-949.e16	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29033130	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Urol. 2018 Feb;15(2):92-111	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29133939	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2017 Nov 13;32(5):550-551	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29136502	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2017 Nov 13;32(5):701-715.e7	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29136510	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2018 Apr;37(14):1911-1925	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29367767	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Dec 16;9(4):4537-4548	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29435122	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 Feb 22;554(7693):544-548	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29443960	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Feb 27;8(1):3737	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29487377	    </ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2018 Jun 10;36(17):1685-1694	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29489427	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2018 Jun;24(6):758-769	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29785026	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2018 Jul;8(7):812-821	  </Citation><ArticleIdList><ArticleId IdType="pubmed">29848605	    </ArticleId></ArticleIdList></Reference><Reference><Citation>Mod Pathol. 2018 Dec;31(12):1869-1881	</Citation><ArticleIdList><ArticleId IdType="pubmed">29967424	</ArticleId></ArticleIdList></Reference><Reference><Citation>Urol Oncol. 2018 Nov 13;:null	</Citation><ArticleIdList><ArticleId IdType="pubmed">30446446	</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30035181	  </PMID><DateRevised><Year>2020	    </Year><Month>10	    </Month><Day>01	    </Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2331-4737	</ISSN><JournalIssue CitedMedium="Print"><Volume>5	</Volume><Issue>5-6	</Issue><PubDate><Year>2018	</Year><Month>May	</Month></PubDate></JournalIssue><Title>Oncoscience	</Title><ISOAbbreviation>Oncoscience	</ISOAbbreviation></Journal><ArticleTitle>The BBN model: a mouse bladder cancer model featuring basal-subtype gene expression and MLL3/MLL4 genetic disruption.	</ArticleTitle><Pagination><MedlinePgn>172-173	</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncoscience.439	</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fantini	</LastName><ForeName>Damiano	</ForeName><Initials>D	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine Northwestern University, Chicago, IL 60611, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeks	</LastName><ForeName>Joshua J	</ForeName><Initials>JJ	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine Northwestern University, Chicago, IL 60611, USA.	</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng	</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX003692	</GrantID><Acronym>BX	</Acronym><Agency>BLRD VA	</Agency><Country>United States	</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial	</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018	</Year><Month>06	</Month><Day>29	</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States	</Country><MedlineTA>Oncoscience	</MedlineTA><NlmUniqueID>101636666	</NlmUniqueID><ISSNLinking>2331-4737	</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BBN tumors	</Keyword><Keyword MajorTopicYN="N">bladder cancer	</Keyword><Keyword MajorTopicYN="N">cancer genomics	</Keyword><Keyword MajorTopicYN="N">cancer models	</Keyword><Keyword MajorTopicYN="N">epigenetic factors	</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST The authors declare that they have no competing interests.	</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018	</Year><Month>05	</Month><Day>02	</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018	</Year><Month>05	</Month><Day>09	</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018	</Year><Month>7	</Month><Day>24	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018	</Year><Month>7	</Month><Day>24	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018	</Year><Month>7	</Month><Day>24	</Day><Hour>6	</Hour><Minute>1	</Minute></PubMedPubDate></History><PublicationStatus>epublish	</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30035181	</ArticleId><ArticleId IdType="doi">10.18632/oncoscience.439	</ArticleId><ArticleId IdType="pii">439	</ArticleId><ArticleId IdType="pmc">PMC6049309	</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Cancer. 2015 Mar 1;136(5):E359-86	</Citation><ArticleIdList><ArticleId IdType="pubmed">25220842	</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2018 Apr;37(14):1911-1925	</Citation><ArticleIdList><ArticleId IdType="pubmed">29367767	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Oct 19;171(3):540-556.e25	</Citation><ArticleIdList><ArticleId IdType="pubmed">28988769	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2016 Jun;48(6):600-606	</Citation><ArticleIdList><ArticleId IdType="pubmed">27111033	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Aug 22;500(7463):415-21	</Citation><ArticleIdList><ArticleId IdType="pubmed">23945592	</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Dec 16;9(4):4537-4548	</Citation><ArticleIdList><ArticleId IdType="pubmed">29435122	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Aug 07;43(9):875-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">21822268	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Urol. 2017 Feb 07;14(4):215-229	</Citation><ArticleIdList><ArticleId IdType="pubmed">28169993	</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29785026	</PMID><DateCompleted><Year>2019	</Year><Month>05	</Month><Day>13	</Day></DateCompleted><DateRevised><Year>2019	</Year><Month>12	</Month><Day>10	</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X	</ISSN><JournalIssue CitedMedium="Internet"><Volume>24	</Volume><Issue>6	</Issue><PubDate><Year>2018	</Year><Month>06	</Month></PubDate></JournalIssue><Title>Nature medicine	</Title><ISOAbbreviation>Nat Med	</ISOAbbreviation></Journal><ArticleTitle>Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	</ArticleTitle><Pagination><MedlinePgn>758-769	</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-018-0034-6	</ELocationID><Abstract><AbstractText>The lysine methyltransferase KMT2C (also known as MLL3), a subunit of the COMPASS complex, implements monomethylation of Lys4 on histone H3 (H3K4) at gene enhancers. KMT2C (hereafter referred to as MLL3) frequently incurs point mutations across a range of human tumor types, but precisely how these lesions alter MLL3 function and contribute to oncogenesis is unclear. Here we report a cancer mutational hotspot in MLL3 within the region encoding its plant homeodomain (PHD) repeats and demonstrate that this domain mediates association of MLL3 with the histone H2A deubiquitinase and tumor suppressor BAP1. Cancer-associated mutations in the sequence encoding the MLL3 PHD repeats disrupt the interaction between MLL3 and BAP1 and correlate with poor patient survival. Cancer cells that had PHD-associated MLL3 mutations or lacked BAP1 showed reduced recruitment of MLL3 and the H3K27 demethylase KDM6A (also known as UTX) to gene enhancers. As a result, inhibition of the H3K27 methyltransferase activity of the Polycomb repressive complex 2 (PRC2) in tumor cells harboring BAP1 or MLL3 mutations restored normal gene expression patterns and impaired cell proliferation in vivo. This study provides mechanistic insight into the oncogenic effects of PHD-associated mutations in MLL3 and suggests that restoration of a balanced state of Polycomb-COMPASS activity may have therapeutic efficacy in tumors that bear mutations in the genes encoding these epigenetic factors.	</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang	</LastName><ForeName>Lu	</ForeName><Initials>L	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao	</LastName><ForeName>Zibo	</ForeName><Initials>Z	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozark	</LastName><ForeName>Patrick A	</ForeName><Initials>PA	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantini	</LastName><ForeName>Damiano	</ForeName><Initials>D	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall	</LastName><ForeName>Stacy A	</ForeName><Initials>SA	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rendleman	</LastName><ForeName>Emily J	</ForeName><Initials>EJ	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzolino	</LastName><ForeName>Kira A	</ForeName><Initials>KA	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louis	</LastName><ForeName>Nundia	</ForeName><Initials>N	</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He	</LastName><ForeName>Xingyao	</ForeName><Initials>X	</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan	</LastName><ForeName>Marc A	</ForeName><Initials>MA	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi	</LastName><ForeName>Yoh-Hei	</ForeName><Initials>YH	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collings	</LastName><ForeName>Clayton K	</ForeName><Initials>CK	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith	</LastName><ForeName>Edwin R	</ForeName><Initials>ER	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntziachristos	</LastName><ForeName>Panagiotis	</ForeName><Initials>P	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savas	</LastName><ForeName>Jeffrey N	</ForeName><Initials>JN	</Initials><AffiliationInfo><Affiliation>Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou	</LastName><ForeName>Lihua	</ForeName><Initials>L	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashizume	</LastName><ForeName>Rintaro	</ForeName><Initials>R	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeks	</LastName><ForeName>Joshua J	</ForeName><Initials>JJ	</Initials><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shilatifard	</LastName><ForeName>Ali	</ForeName><Initials>A	</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7490-2854	</Identifier><AffiliationInfo><Affiliation>Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. ash@northwestern.edu.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. ash@northwestern.edu.	</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng	</Language><GrantList CompleteYN="Y"><Grant><GrantID>R50 CA211428	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>R35 CA197569	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>R00 DC013805	</GrantID><Acronym>DC	</Acronym><Agency>NIDCD NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>R01 NS093079	</GrantID><Acronym>NS	</Acronym><Agency>NINDS NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>I01 BX003692	</GrantID><Acronym>BX	</Acronym><Agency>BLRD VA	</Agency><Country>United States	</Country></Grant><Grant><GrantID>T32 CA070085	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article	</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural	</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't	</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018	</Year><Month>05	</Month><Day>21	</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States	</Country><MedlineTA>Nat Med	</MedlineTA><NlmUniqueID>9502015	</NlmUniqueID><ISSNLinking>1078-8956	</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="C400134">BAP1 protein, human	</NameOfSubstance></Chemical><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="D002843">Chromatin	</NameOfSubstance></Chemical><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins	</NameOfSubstance></Chemical><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="C452979">KMT2C protein, human	</NameOfSubstance></Chemical><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins	</NameOfSubstance></Chemical><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="D063146">Polycomb-Group Proteins	</NameOfSubstance></Chemical><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="D025521">Tumor Suppressor Proteins	</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.11.-	</RegistryNumber><NameOfSubstance UI="D056466">Histone Demethylases	</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.11.-	</RegistryNumber><NameOfSubstance UI="C523998">KDM6A protein, human	</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12	</RegistryNumber><NameOfSubstance UI="D043222">Ubiquitin Thiolesterase	</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM	</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002843" MajorTopicYN="N">Chromatin	</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins	</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry	</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004742" MajorTopicYN="Y">Enhancer Elements, Genetic	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056466" MajorTopicYN="N">Histone Demethylases	</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation	</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins	</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075925" MajorTopicYN="N">PHD Zinc Fingers	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063146" MajorTopicYN="N">Polycomb-Group Proteins	</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025521" MajorTopicYN="N">Tumor Suppressor Proteins	</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043222" MajorTopicYN="N">Ubiquitin Thiolesterase	</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism	</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017	</Year><Month>10	</Month><Day>17	</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018	</Year><Month>03	</Month><Day>21	</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018	</Year><Month>5	</Month><Day>23	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019	</Year><Month>5	</Month><Day>14	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018	</Year><Month>5	</Month><Day>23	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate></History><PublicationStatus>ppublish	</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29785026	</ArticleId><ArticleId IdType="doi">10.1038/s41591-018-0034-6	</ArticleId><ArticleId IdType="pii">10.1038/s41591-018-0034-6	</ArticleId><ArticleId IdType="pmc">PMC6055231	</ArticleId><ArticleId IdType="mid">NIHMS980925	</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bioinformatics. 2015 Jan 15;31(2):166-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">25260700	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2013 Nov;14(11):765-80	</Citation><ArticleIdList><ArticleId IdType="pubmed">24105274	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2012 Dec 1;26(23):2604-20	</Citation><ArticleIdList><ArticleId IdType="pubmed">23166019	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Signal. 2013 May;25(5):1245-51	</Citation><ArticleIdList><ArticleId IdType="pubmed">23357533	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2014;15(12):554	</Citation><ArticleIdList><ArticleId IdType="pubmed">25476604	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Jul 27;170(3):577-592.e10	</Citation><ArticleIdList><ArticleId IdType="pubmed">28753431	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Oct 17;502(7471):333-339	</Citation><ArticleIdList><ArticleId IdType="pubmed">24132290	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Jan 1;26(1):139-40	</Citation><ArticleIdList><ArticleId IdType="pubmed">19910308	</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Jun 3;352(6290):aad9780	</Citation><ArticleIdList><ArticleId IdType="pubmed">27257261	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Oct;21(10):1190-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">26366712	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2010 Apr 15;70(8):3287-98	</Citation><ArticleIdList><ArticleId IdType="pubmed">20388784	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2007 Feb 9;25(3):473-81	</Citation><ArticleIdList><ArticleId IdType="pubmed">17289593	</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2012 Sep 21;337(6101):1541-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">22878500	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2004 Aug;6(8):731-40	</Citation><ArticleIdList><ArticleId IdType="pubmed">15235609	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20526-31	</Citation><ArticleIdList><ArticleId IdType="pubmed">22158900	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12902-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">11687631	</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 2014 Sep;350(3):646-56	</Citation><ArticleIdList><ArticleId IdType="pubmed">24993360	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Nov 22;20(17):3246-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">15180930	</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2014 Aug 29;345(6200):1065-70	</Citation><ArticleIdList><ArticleId IdType="pubmed">25170156	</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncol Rep. 2014 May;31(5):2351-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">24676361	</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis. 2012 Dec;33(12):2326-33	</Citation><ArticleIdList><ArticleId IdType="pubmed">22941060	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Jun 12;510(7504):283-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">24847881	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Jun 10;486(7403):353-60	</Citation><ArticleIdList><ArticleId IdType="pubmed">22722193	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 2013 Dec;33(23):4745-54	</Citation><ArticleIdList><ArticleId IdType="pubmed">24081332	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2010 May 28;38(4):576-89	</Citation><ArticleIdList><ArticleId IdType="pubmed">20513432	</ArticleId></ArticleIdList></Reference><Reference><Citation>Structure. 2011 Sep 7;19(9):1262-73	</Citation><ArticleIdList><ArticleId IdType="pubmed">21782458	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2013 Mar;13(3):153-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">23550303	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2016 Jun 7;22(6):577-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">27270772	</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2013 Apr 02;6(269):pl1	</Citation><ArticleIdList><ArticleId IdType="pubmed">23550210	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):18928-33	</Citation><ArticleIdList><ArticleId IdType="pubmed">17138671	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2010 May;28(5):495-501	</Citation><ArticleIdList><ArticleId IdType="pubmed">20436461	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2008;9(9):R137	</Citation><ArticleIdList><ArticleId IdType="pubmed">18798982	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2012 Apr 13;149(2):498-498.e1	</Citation><ArticleIdList><ArticleId IdType="pubmed">22500810	</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2015 May 14;34(20):2575-85	</Citation><ArticleIdList><ArticleId IdType="pubmed">25023701	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2016 Sep 15;30(18):2021-2041	</Citation><ArticleIdList><ArticleId IdType="pubmed">27798847	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 Dec 9;18(6):723-35	</Citation><ArticleIdList><ArticleId IdType="pubmed">26651948	</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2017 Mar 24;355(6331):1324-1330	</Citation><ArticleIdList><ArticleId IdType="pubmed">28336670	</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biochem. 2012;81:65-95	</Citation><ArticleIdList><ArticleId IdType="pubmed">22663077	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2011 Oct 1;71(19):6106-15	</Citation><ArticleIdList><ArticleId IdType="pubmed">21844183	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2007 Feb 23;128(4):693-705	</Citation><ArticleIdList><ArticleId IdType="pubmed">17320507	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):18993-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">18025461	</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2013 Feb 21;121(8):1478-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">23429989	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 2013 May;33(9):1698-701	</Citation><ArticleIdList><ArticleId IdType="pubmed">23459940	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Nov;21(11):1344-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">26437366	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2014 May 12;25(5):652-65	</Citation><ArticleIdList><ArticleId IdType="pubmed">24794707	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Jul 20;535(7612):382-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">27443740	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Oct;21(10):1199-208	</Citation><ArticleIdList><ArticleId IdType="pubmed">26366710	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2007 Jan 1;21(1):49-54	</Citation><ArticleIdList><ArticleId IdType="pubmed">17210787	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2012 May;2(5):401-4	</Citation><ArticleIdList><ArticleId IdType="pubmed">22588877	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2017 Oct 15;31(20):2056-2066	</Citation><ArticleIdList><ArticleId IdType="pubmed">29138278	</ArticleId></ArticleIdList></Reference><Reference><Citation>Gynecol Oncol. 2016 Mar;140(3):545-53	</Citation><ArticleIdList><ArticleId IdType="pubmed">26691219	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10632-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">9724755	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2013 Oct 15;73(20):6299-309	</Citation><ArticleIdList><ArticleId IdType="pubmed">23943797	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2015 Feb 1;29(3):238-49	</Citation><ArticleIdList><ArticleId IdType="pubmed">25644600	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2012 May 27;44(7):760-4	</Citation><ArticleIdList><ArticleId IdType="pubmed">22634756	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Aug 07;43(9):875-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">21822268	</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2014 Apr 15;15:284	</Citation><ArticleIdList><ArticleId IdType="pubmed">24735413	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Mar 3;531(7592):47-52	</Citation><ArticleIdList><ArticleId IdType="pubmed">26909576	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2016 Jun 7;22(6):578-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">27270773	</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29435122	</PMID><DateRevised><Year>2019	</Year><Month>11	</Month><Day>20	</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553	</ISSN><JournalIssue CitedMedium="Internet"><Volume>9	</Volume><Issue>4	</Issue><PubDate><Year>2018	</Year><Month>Jan	</Month><Day>12	</Day></PubDate></JournalIssue><Title>Oncotarget	</Title><ISOAbbreviation>Oncotarget	</ISOAbbreviation></Journal><ArticleTitle>APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.	</ArticleTitle><Pagination><MedlinePgn>4537-4548	</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.23344	</ELocationID><Abstract><AbstractText>APOBEC enzymes are responsible for a mutation signature (TCW&gt;T/G) implicated in a wide variety of tumors. We explore the APOBEC mutational signature in bladder cancer and the relationship with specific mutations, molecular subtype, gene expression, and survival using sequencing data from The Cancer Genome Atlas (<i>n	</i> = 395), Beijing Genomics Institute (<i>n	</i> = 99), and Cancer Cell Line Encyclopedia. Tumors were split into &quot;APOBEC-high&quot; and &quot;APOBEC-low&quot; based on APOBEC enrichment. Patients with APOBEC-high tumors have better overall survival compared to those with APOBEC-low tumors (38.2 vs. 18.5 months, <i>p	</i> = 0.005). APOBEC-high tumors are more likely to have mutations in DNA damage response genes (<i>TP53, ATR, BRCA2	</i>) and chromatin regulatory genes (<i>ARID1A, MLL, MLL3	</i>), while APOBEC-low tumors are more likely to have mutations in <i>FGFR3	</i> and <i>KRAS	</i>. <i>APOBEC3A	</i> and <i>APOBEC3B	</i> expression correlates with mutation burden, regardless of bladder tumor molecular subtype. APOBEC mutagenesis is associated with increased expression of immune signatures, including interferon signaling, and expression of <i>APOBEC3B	</i> is increased after stimulation of APOBEC-high bladder cancer cell lines with IFNγ. In summary, APOBEC-high tumors are more likely to have mutations in DNA damage response and chromatin regulatory genes, potentially providing more substrate for APOBEC enzymes, leading to a hypermutational phenotype and the subsequent enhanced immune response.	</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glaser	</LastName><ForeName>Alexander P	</ForeName><Initials>AP	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantini	</LastName><ForeName>Damiano	</ForeName><Initials>D	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang	</LastName><ForeName>Yiduo	</ForeName><Initials>Y	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu	</LastName><ForeName>Yanni	</ForeName><Initials>Y	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimar	</LastName><ForeName>Kalen J	</ForeName><Initials>KJ	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podojil	</LastName><ForeName>Joseph R	</ForeName><Initials>JR	</Initials><AffiliationInfo><Affiliation>Interdepartmental Immunobiology Center, Department of Microbiology-Immunology, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller	</LastName><ForeName>Stephen D	</ForeName><Initials>SD	</Initials><AffiliationInfo><Affiliation>Interdepartmental Immunobiology Center, Department of Microbiology-Immunology, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeks	</LastName><ForeName>Joshua J	</ForeName><Initials>JJ	</Initials><AffiliationInfo><Affiliation>Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng	</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX003692	</GrantID><Acronym>BX	</Acronym><Agency>BLRD VA	</Agency><Country>United States	</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article	</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017	</Year><Month>12	</Month><Day>16	</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States	</Country><MedlineTA>Oncotarget	</MedlineTA><NlmUniqueID>101532965	</NlmUniqueID><ISSNLinking>1949-2553	</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APOBEC deaminases	</Keyword><Keyword MajorTopicYN="N">DNA damage	</Keyword><Keyword MajorTopicYN="N">interferon	</Keyword><Keyword MajorTopicYN="N">mutagenesis	</Keyword><Keyword MajorTopicYN="N">urinary bladder neoplasms	</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST The authors declare no competing interest.	</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017	</Year><Month>09	</Month><Day>13	</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017	</Year><Month>11	</Month><Day>26	</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018	</Year><Month>2	</Month><Day>14	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018	</Year><Month>2	</Month><Day>13	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018	</Year><Month>2	</Month><Day>13	</Day><Hour>6	</Hour><Minute>1	</Minute></PubMedPubDate></History><PublicationStatus>epublish	</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29435122	</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.23344	</ArticleId><ArticleId IdType="pii">23344	</ArticleId><ArticleId IdType="pmc">PMC5796993	</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Genome Biol. 2016 Sep 15;17 (1):185	</Citation><ArticleIdList><ArticleId IdType="pubmed">27634334	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Feb 21;494(7437):366-70	</Citation><ArticleIdList><ArticleId IdType="pubmed">23389445	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 Jan 28;164(3):538-49	</Citation><ArticleIdList><ArticleId IdType="pubmed">26806129	</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomol Struct Dyn. 2017 Sep;35(12 ):2745-2757	</Citation><ArticleIdList><ArticleId IdType="pubmed">27581627	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Jul;38(13):4274-84	</Citation><ArticleIdList><ArticleId IdType="pubmed">20308164	</ArticleId></ArticleIdList></Reference><Reference><Citation>Leukemia. 2016 Aug;30(8):1672-81	</Citation><ArticleIdList><ArticleId IdType="pubmed">27063598	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Jan 1;26(1):139-40	</Citation><ArticleIdList><ArticleId IdType="pubmed">19910308	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2012 May 25;46(4):424-35	</Citation><ArticleIdList><ArticleId IdType="pubmed">22607975	</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Aug 04;12:323	</Citation><ArticleIdList><ArticleId IdType="pubmed">21816040	</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2012 Dec 18;7:47; discussion 47	</Citation><ArticleIdList><ArticleId IdType="pubmed">23249472	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">27141961	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2015 Jul;5(7):704-12	</Citation><ArticleIdList><ArticleId IdType="pubmed">26091828	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Dec;45(12):1459-63	</Citation><ArticleIdList><ArticleId IdType="pubmed">24121792	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2009 Jan;37(1):1-13	</Citation><ArticleIdList><ArticleId IdType="pubmed">19033363	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2016 Nov;48(11):1330-1338	</Citation><ArticleIdList><ArticleId IdType="pubmed">27643540	</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2016 Oct;12 :105-117	</Citation><ArticleIdList><ArticleId IdType="pubmed">27612592	</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2017 Jun;12 (6):943-953	</Citation><ArticleIdList><ArticleId IdType="pubmed">28341226	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2017 Feb;24(2):131-139	</Citation><ArticleIdList><ArticleId IdType="pubmed">27991903	</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Oncol. 2016 Aug 1;2(8):1094-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">27310333	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 Apr;10 (4):293-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">23538863	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2014 Jun 26;7(6):1833-41	</Citation><ArticleIdList><ArticleId IdType="pubmed">24910434	</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatology. 2006 Jun;43(6):1364-74	</Citation><ArticleIdList><ArticleId IdType="pubmed">16729314	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Inform. 2016 Jun 12;15:103-14	</Citation><ArticleIdList><ArticleId IdType="pubmed">27330269	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Jul 3;424(6944):99-103	</Citation><ArticleIdList><ArticleId IdType="pubmed">12808466	</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Mol Med. 2015 May;21(5):274-84	</Citation><ArticleIdList><ArticleId IdType="pubmed">25820175	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Sep;45(9):977-83	</Citation><ArticleIdList><ArticleId IdType="pubmed">23852168	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Jul 11;499(7457):214-218	</Citation><ArticleIdList><ArticleId IdType="pubmed">23770567	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2015 Apr 28;7(1):38	</Citation><ArticleIdList><ArticleId IdType="pubmed">26015808	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2012 May;40(10):4288-97	</Citation><ArticleIdList><ArticleId IdType="pubmed">22287627	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2014 Oct;4(10):1140-53	</Citation><ArticleIdList><ArticleId IdType="pubmed">25096233	</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2013 Apr 15;14:128	</Citation><ArticleIdList><ArticleId IdType="pubmed">23586463	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 Feb;12(2):115-21	</Citation><ArticleIdList><ArticleId IdType="pubmed">25633503	</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Oncol. 2016 Apr;2(4):471-80	</Citation><ArticleIdList><ArticleId IdType="pubmed">26746117	</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Rep. 2011 May;12(5):444-50	</Citation><ArticleIdList><ArticleId IdType="pubmed">21460793	</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2013 Oct 17;39(4):782-95	</Citation><ArticleIdList><ArticleId IdType="pubmed">24138885	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2012 May;2(5):401-4	</Citation><ArticleIdList><ArticleId IdType="pubmed">22588877	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2016 Sep 30;17 (1):202	</Citation><ArticleIdList><ArticleId IdType="pubmed">27716362	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Mar 28;483(7391):603-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">22460905	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2015 Sep;47(9):1067-72	</Citation><ArticleIdList><ArticleId IdType="pubmed">26258849	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Feb 9;168(4):644-656	</Citation><ArticleIdList><ArticleId IdType="pubmed">28187286	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2017 Nov 13;32(5):701-715.e7	</Citation><ArticleIdList><ArticleId IdType="pubmed">29136510	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2009;4(1):44-57	</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956	</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Aug 20;8(8):e73641	</Citation><ArticleIdList><ArticleId IdType="pubmed">23977391	</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2015 Dec;68(6):959-67	</Citation><ArticleIdList><ArticleId IdType="pubmed">26238431	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Sep;45(9):970-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">23852170	</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2017 Jun 27;117(1):113-123	</Citation><ArticleIdList><ArticleId IdType="pubmed">28535155	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2002 Nov;10 (5):1247-53	</Citation><ArticleIdList><ArticleId IdType="pubmed">12453430	</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Jun 6;300(5625):1542-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">12791985	</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29367767	</PMID><DateCompleted><Year>2019	</Year><Month>03	</Month><Day>07	</Day></DateCompleted><DateRevised><Year>2019	</Year><Month>06	</Month><Day>10	</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5594	</ISSN><JournalIssue CitedMedium="Internet"><Volume>37	</Volume><Issue>14	</Issue><PubDate><Year>2018	</Year><Month>04	</Month></PubDate></JournalIssue><Title>Oncogene	</Title><ISOAbbreviation>Oncogene	</ISOAbbreviation></Journal><ArticleTitle>A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.	</ArticleTitle><Pagination><MedlinePgn>1911-1925	</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41388-017-0099-6	</ELocationID><Abstract><AbstractText>The N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) mouse model is an attractive model system of muscle-invasive bladder cancer (MIBC) as it recapitulates the histology of human tumors in a background with intact immune system. However, it was unknown whether this carcinogen-induced model also mimicked human MIBC at the molecular and mutational level. In our study, we analyzed gene expression and mutational landscape of the BBN model by next-generation sequencing followed by a bioinformatic comparison to human MIBC using data from The Cancer Genome Atlas and other repositories. BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC. Many variants corresponded to human cancer hotspot mutations, supporting their role as driver mutations. We extracted two novel mutational signatures from the BBN mouse genomes. The integrated analysis of mutation frequencies and signatures highlighted the contribution of aberrations to chromatin regulators and genetic instability in the BBN tumors. Together, our study revealed several similarities between human MIBC and the BBN mouse model, providing a strong rationale for its use in molecular and drug discovery studies.	</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fantini	</LastName><ForeName>Damiano	</ForeName><Initials>D	</Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glaser	</LastName><ForeName>Alexander P	</ForeName><Initials>AP	</Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimar	</LastName><ForeName>Kalen J	</ForeName><Initials>KJ	</Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang	</LastName><ForeName>Yiduo	</ForeName><Initials>Y	</Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schipma	</LastName><ForeName>Matthew	</ForeName><Initials>M	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varghese	</LastName><ForeName>Nobish	</ForeName><Initials>N	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rademaker	</LastName><ForeName>Alfred	</ForeName><Initials>A	</Initials><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behdad	</LastName><ForeName>Amir	</ForeName><Initials>A	</Initials><AffiliationInfo><Affiliation>Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yellapa	</LastName><ForeName>Aparna	</ForeName><Initials>A	</Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu	</LastName><ForeName>Yanni	</ForeName><Initials>Y	</Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sze	</LastName><ForeName>Christie Ching-Lin	</ForeName><Initials>CC	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang	</LastName><ForeName>Lu	</ForeName><Initials>L	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao	</LastName><ForeName>Zibo	</ForeName><Initials>Z	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crawford	</LastName><ForeName>Susan E	</ForeName><Initials>SE	</Initials><AffiliationInfo><Affiliation>Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu	</LastName><ForeName>Deqing	</ForeName><Initials>D	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licht	</LastName><ForeName>Jonathan D	</ForeName><Initials>JD	</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology and Oncology, University of Florida, Gainesville, FL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collings	</LastName><ForeName>Clayton K	</ForeName><Initials>CK	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartom	</LastName><ForeName>Elizabeth	</ForeName><Initials>E	</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodorescu	</LastName><ForeName>Dan	</ForeName><Initials>D	</Initials><AffiliationInfo><Affiliation>Department of Surgery (Urology) and Pharmacology, Comprehensive Cancer Center, University of Colorado, Denver, CO, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shilatifard	</LastName><ForeName>Ali	</ForeName><Initials>A	</Initials><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.	</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeks	</LastName><ForeName>Joshua J	</ForeName><Initials>JJ	</Initials><AffiliationInfo><Affiliation>Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. joshua.meeks@northwestern.edu.	</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. joshua.meeks@northwestern.edu.	</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng	</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA075115	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>T32 CA009560	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>R35 CA197569	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>I01 BX003692	</GrantID><Acronym>BX	</Acronym><Agency>BLRD VA	</Agency><Country>United States	</Country></Grant><Grant><GrantID>R01 CA180475	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant><Grant><GrantID>R29 CA075115	</GrantID><Acronym>CA	</Acronym><Agency>NCI NIH HHS	</Agency><Country>United States	</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article	</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural	</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't	</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018	</Year><Month>01	</Month><Day>25	</Day></ArticleDate></Article><MedlineJournalInfo><Country>England	</Country><MedlineTA>Oncogene	</MedlineTA><NlmUniqueID>8711562	</NlmUniqueID><ISSNLinking>0950-9232	</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0	</RegistryNumber><NameOfSubstance UI="D002273">Carcinogens	</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM	</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002273" MajorTopicYN="Y">Carcinogens	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002295" MajorTopicYN="N">Carcinoma, Transitional Cell	</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced	</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic	</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects	</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic	</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046228" MajorTopicYN="N">Microarray Analysis	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019042" MajorTopicYN="N">Muscle Neoplasms	</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced	</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	</QualifierName><QualifierName UI="Q000556" MajorTopicYN="Y">secondary	</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome	</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms	</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced	</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics	</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology	</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017	</Year><Month>07	</Month><Day>23	</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017	</Year><Month>12	</Month><Day>03	</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017	</Year><Month>10	</Month><Day>21	</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018	</Year><Month>1	</Month><Day>26	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019	</Year><Month>3	</Month><Day>8	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018	</Year><Month>1	</Month><Day>26	</Day><Hour>6	</Hour><Minute>0	</Minute></PubMedPubDate></History><PublicationStatus>ppublish	</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29367767	</ArticleId><ArticleId IdType="doi">10.1038/s41388-017-0099-6	</ArticleId><ArticleId IdType="pii">10.1038/s41388-017-0099-6	</ArticleId><ArticleId IdType="pmc">PMC5886988	</ArticleId><ArticleId IdType="mid">NIHMS925052	</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Cell Biol. 2014 Oct;16(10):982-91, 1-5	</Citation><ArticleIdList><ArticleId IdType="pubmed">25218638	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2015 Jan;15(1):42-54	</Citation><ArticleIdList><ArticleId IdType="pubmed">25533675	</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2012 Nov 04;13:591	</Citation><ArticleIdList><ArticleId IdType="pubmed">23442169	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2009 Mar 15;23 (6):675-80	</Citation><ArticleIdList><ArticleId IdType="pubmed">19261747	</ArticleId></ArticleIdList></Reference><Reference><Citation>JCI Insight. 2016 Mar 17;1(3):e85902	</Citation><ArticleIdList><ArticleId IdType="pubmed">27699256	</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 May 7;387(10031):1909-20	</Citation><ArticleIdList><ArticleId IdType="pubmed">26952546	</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2011 Sep 15;129(6):1532-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">21413016	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Feb 1;28(3):423-5	</Citation><ArticleIdList><ArticleId IdType="pubmed">22155870	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Jan 1;26(1):139-40	</Citation><ArticleIdList><ArticleId IdType="pubmed">19910308	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D472-7	</Citation><ArticleIdList><ArticleId IdType="pubmed">24243840	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2016 May;16(5):275-87	</Citation><ArticleIdList><ArticleId IdType="pubmed">27079802	</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2015 Jan;26(1):64-70	</Citation><ArticleIdList><ArticleId IdType="pubmed">25319062	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2010 Mar 19;140(6):883-99	</Citation><ArticleIdList><ArticleId IdType="pubmed">20303878	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Dec;45(12):1459-63	</Citation><ArticleIdList><ArticleId IdType="pubmed">24121792	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 May 1;25(9):1105-11	</Citation><ArticleIdList><ArticleId IdType="pubmed">19289445	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2016 Jun;48(6):600-606	</Citation><ArticleIdList><ArticleId IdType="pubmed">27111033	</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2017 Jan 5;36(1):35-46	</Citation><ArticleIdList><ArticleId IdType="pubmed">27270441	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Jan 18;481(7381):306-13	</Citation><ArticleIdList><ArticleId IdType="pubmed">22258609	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2012 Mar;40(6):2494-505	</Citation><ArticleIdList><ArticleId IdType="pubmed">22121226	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Apr 15;464(7291):999-1005	</Citation><ArticleIdList><ArticleId IdType="pubmed">20393555	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2014 May;16(5):469-78	</Citation><ArticleIdList><ArticleId IdType="pubmed">24747439	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2010 May;28(5):511-5	</Citation><ArticleIdList><ArticleId IdType="pubmed">20436464	</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2017 Apr 8;17 (1):252	</Citation><ArticleIdList><ArticleId IdType="pubmed">28390392	</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Jul 05;6:29479	</Citation><ArticleIdList><ArticleId IdType="pubmed">27378170	</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nucleic Acids. 2010 Sep 05;2010:null	</Citation><ArticleIdList><ArticleId IdType="pubmed">20871819	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Mar 20;507(7492):315-22	</Citation><ArticleIdList><ArticleId IdType="pubmed">24476821	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Urol. 2017 Feb 07;14 (4):215-229	</Citation><ArticleIdList><ArticleId IdType="pubmed">28169993	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):null	</Citation><ArticleIdList><ArticleId IdType="pubmed">27836911	</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2016 Nov;17 (11):1590-1598	</Citation><ArticleIdList><ArticleId IdType="pubmed">27733243	</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2016 Oct;12 :105-117	</Citation><ArticleIdList><ArticleId IdType="pubmed">27612592	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50	</Citation><ArticleIdList><ArticleId IdType="pubmed">20876136	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Aug 15;25(16):2078-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">19505943	</ArticleId></ArticleIdList></Reference><Reference><Citation>In Vivo. 2012 Jul-Aug;26(4):727-39	</Citation><ArticleIdList><ArticleId IdType="pubmed">22773588	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Sep 19;501(7467):338-45	</Citation><ArticleIdList><ArticleId IdType="pubmed">24048066	</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2013 Apr 02;6(269):pl1	</Citation><ArticleIdList><ArticleId IdType="pubmed">23550210	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2000 Aug 1;89(3):630-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">10931463	</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2012 Jan;109(1):52-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">21592300	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 May 26;106(21):8513-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">19433796	</ArticleId></ArticleIdList></Reference><Reference><Citation>Gend Med. 2008 Dec;5(4):385-94	</Citation><ArticleIdList><ArticleId IdType="pubmed">19108811	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 1977 Feb;37(2):399-407	</Citation><ArticleIdList><ArticleId IdType="pubmed">318920	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2015 Apr 28;7(1):38	</Citation><ArticleIdList><ArticleId IdType="pubmed">26015808	</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 1979 Apr;62(4):1017-23	</Citation><ArticleIdList><ArticleId IdType="pubmed">107359	</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2001 Feb 1;19(3):666-75	</Citation><ArticleIdList><ArticleId IdType="pubmed">11157016	</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 May 22;109 (21):8241-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">22493262	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2013 Mar;23(3):555-67	</Citation><ArticleIdList><ArticleId IdType="pubmed">23325432	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Aug 22;500(7463):415-21	</Citation><ArticleIdList><ArticleId IdType="pubmed">23945592	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold Spring Harb Perspect Med. 2016 Nov 1;6(11):null	</Citation><ArticleIdList><ArticleId IdType="pubmed">27638352	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2014 Oct;4(10):1140-53	</Citation><ArticleIdList><ArticleId IdType="pubmed">25096233	</ArticleId></ArticleIdList></Reference><Reference><Citation>Fly (Austin). 2012 Apr-Jun;6(2):80-92	</Citation><ArticleIdList><ArticleId IdType="pubmed">22728672	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cancer Res. 2016 Jan;14 (1):3-13	</Citation><ArticleIdList><ArticleId IdType="pubmed">26248648	</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Jul 02;11:367	</Citation><ArticleIdList><ArticleId IdType="pubmed">20598126	</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2016 Feb 22;17 :31	</Citation><ArticleIdList><ArticleId IdType="pubmed">26899170	</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2016 Feb;12 (2):477-9	</Citation><ArticleIdList><ArticleId IdType="pubmed">26661513	</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Jul 15;25(14):1754-60	</Citation><ArticleIdList><ArticleId IdType="pubmed">19451168	</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2014 Feb 10;25(2):152-65	</Citation><ArticleIdList><ArticleId IdType="pubmed">24525232	</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30	</Citation><ArticleIdList><ArticleId IdType="pubmed">26742998	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Sep;45(9):970-6	</Citation><ArticleIdList><ArticleId IdType="pubmed">23852170	</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Aug 07;43(9):875-8	</Citation><ArticleIdList><ArticleId IdType="pubmed">21822268	</ArticleId></ArticleIdList></Reference><Reference><Citation>Discov Med. 2013 Mar;15(82):188-94	</Citation><ArticleIdList><ArticleId IdType="pubmed">23545047	</ArticleId></ArticleIdList></Reference><Reference><Citation>Neoplasia. 2004 Sep-Oct;6(5):569-77	</Citation><ArticleIdList><ArticleId IdType="pubmed">15548366	</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2017;1525:123-135	</Citation><ArticleIdList><ArticleId IdType="pubmed">27896720	</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>


